Trial

NCT03661567

Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sun Yat-sen University
Collaborators
Condition
Non-small Cell Lung Cancer
Intervention
chest radiation
Why stopped
slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-30